Geraldine Freeman, Commercial Director at Johnson & Johnson Consumer Business in Ireland, discusses the increasing trend towards self-care in Ireland and the importance of the self-care agenda within the context of rising healthcare expenditures; the strong legacy of Johnson & Johnson in Ireland with leadership positions across most market segments; and her thoughts on the convergence between the pharma, consumer care and technology industries.
Can you please provide an overview of the Irish healthcare market beyond the pharmaceutical industry?
While the recent economic crisis has impacted the Irish economy and overall consumer spend overall, the OTC market has actually been rather insulated, seeing steady performance in the past few years
